アッヴィ株式会社
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionGw Henssler & Associates Ltd
Latest Disclosed Ownership1,646 shares
Latest Disclosed Value $ 357,989
Gw Henssler & Associates Ltd reports 2.49% increase in ownership of ABBV / AbbVie Inc.

On May 15, 2026 - Gw Henssler & Associates Ltd filed a 13F-HR form disclosing ownership of 1,646 shares of AbbVie Inc. (MX:ABBV) valued at $357,989 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,606 shares of AbbVie Inc.. This represents a change in shares of 2.49% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 1,646 40 2.49 358 -2.46 0.0169
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 1,606 0 0.00 367 -1.35 0.0177
2026-01-23 2025-09-30 13F ABBVIE COM 00287Y109 1,606 -1,263 -44.02 372 -30.26 0.0186
2025-07-25 2025-06-30 13F ABBVIE COM 00287Y109 2,869 -179 -5.87 533 -16.61 0.0284
2025-05-15 2025-03-31 13F/A-1 ABBVIE COM 00287Y109 3,048 1,814 147.00 639 162.55 0.0366
2025-01-24 2024-12-31 13F ABBVIE COM 00287Y109 1,234 -61 -4.71 244 -4.71 0.0140
2024-10-25 2024-09-30 13F ABBVIE COM 00287Y109 1,295 -796 -38.07 256 -28.77 0.0145
2024-08-01 2024-06-30 13F ABBVIE COM 00287Y109 2,091 -162,032 -98.73 359 -98.80 0.0216
2024-05-07 2024-03-31 13F ABBVIE COM 00287Y109 164,123 -2,696 -1.62 29,887 15.60 1.7555
2024-01-26 2023-12-31 13F ABBVIE COM 00287Y109 166,819 -2,391 -1.41 25,852 2.50 1.7067
2023-10-24 2023-09-30 13F ABBVIE COM 00287Y109 169,210 -1,982 -1.16 25,222 9.36 1.7219
2023-08-02 2023-06-30 13F ABBVIE COM 00287Y109 171,192 -708 -0.41 23,065 -15.81 1.5147
2023-04-26 2023-03-31 13F ABBVIE COM 00287Y109 171,900 -2,566 -1.47 27,396 -2.84 1.8199
2023-02-03 2022-12-31 13F ABBVIE COM 00287Y109 174,466 -983 -0.56 28,195 19.74 1.9798
2022-11-04 2022-09-30 13F ABBVIE COM 00287Y109 175,449 668 0.38 23,547 -12.04 1.7624
2022-08-04 2022-06-30 13F ABBVIE COM 00287Y109 174,781 -1,170 -0.66 26,769 -6.15 1.9874
2022-05-09 2022-03-31 13F ABBVIE COM 00287Y109 175,951 837 0.48 28,524 20.30 1.7325
2022-01-28 2021-12-31 13F ABBVIE COM 00287Y109 175,114 855 0.49 23,710 26.14 1.5124
2021-11-02 2021-09-30 13F ABBVIE COM 00287Y109 174,259 1,931 1.12 18,797 -3.16 1.3039
2021-08-09 2021-06-30 13F ABBVIE COM 00287Y109 172,328 2,738 1.61 19,411 5.76 1.2767
2021-04-28 2021-03-31 13F ABBVIE COM 00287Y109 169,590 6,505 3.99 18,353 5.02 1.3124
2021-02-02 2020-12-31 13F ABBVIE COM 00287Y109 163,085 -1,424 -0.87 17,475 21.28 1.3350
2020-10-22 2020-09-30 13F ABBVIE COM 00287Y109 164,509 3,468 2.15 14,409 -8.87 1.2219
2020-07-21 2020-06-30 13F ABBVIE COM 00287Y109 161,041 15,145 10.38 15,811 42.24 1.3899
2020-04-27 2020-03-31 13F ABBVIE COM 00287Y109 145,896 145,896 11,116 1.1263
2016-04-21 2016-03-31 13F ABBVIE COM 00287Y109 0 0 0 0.0000
2015-10-23 2015-09-30 13F ABBVIE COM 00287Y109 0 0 0 0.0000
2015-07-21 2015-06-30 13F ABBVIE COM 00287Y109 0 -3,495 -100.00 0 -100.00
2015-05-11 2015-03-31 13F ABBVIE COM 00287Y109 3,495 0 0.00 205 -10.48 0.0237
2015-02-06 2014-12-31 13F ABBVIE COM 00287Y109 3,495 -123 -3.40 229 9.57 0.0257
2014-11-07 2014-09-30 13F ABBVIE COM 00287Y109 3,618 -333 -8.43 209 -6.28 0.0253
2014-08-12 2014-06-30 13F ABBVIE COM 00287Y109 3,951 -1,845 -31.83 223 -25.17 0.0270
2014-05-12 2014-03-31 13F AbbVie COM 00287Y109 5,796 77 1.35 298 -1.32 0.0350
2014-02-07 2013-12-31 13F AbbVie COM 00287Y109 5,719 38 0.67 302 18.90 0.0353
2013-11-06 2013-09-30 13F AbbVie COM 00287Y109 5,681 -439 -7.17 254 0.40 0.0328
2013-08-02 2013-06-30 13F AbbVie COM 00287Y109 6,120 6,120 253 0.0348
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.